Drug information for NEO-MEDROL

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
OINTMENT; OPHTHALMIC 0.1%;EQ 3.5MG BASE/GM Discontinued   METHYLPREDNISOLONE; NEOMYCIN SULFATE Neo-Medrol PHARMACIA AND UPJOHN 60645

Drug Adverse Effects information for NEO-MEDROL

Role code Indications Reaction # Reports
PS BLEPHARITIS DEAFNESS 1
PS CONJUNCTIVITIS ALLERGIC DEAFNESS 1
PS INFLAMMATION DEAFNESS 1
SS BLEPHARITIS DEAFNESS 1
SS CONJUNCTIVITIS ALLERGIC DEAFNESS 1
Ads by Google